Gold prices steady ahead of Fed decision; weekly weakness noted
DUBLIN, LONDON - Uniphar plc, a diversified healthcare services company, announced that its shareholders have passed all resolutions at the Annual General Meeting (AGM) on Thursday. The resolutions included the approval of financial statements, final dividend payouts, and the re-election of board members, among others.
The company, which connects pharmaceutical and medical technology manufacturers with healthcare professionals and patients, reported overwhelming support for its agenda items. Notably, the resolution to distribute a final dividend of €3.4 million was approved with 100% of the votes in favor. Additionally, the re-election of the company’s CEO, Ger Rabbette, and other board members received strong backing, with more than 99% of votes cast in their favor.
The AGM also saw the authorization of the company to make market purchases of its ordinary shares and the re-issuance of treasury shares, both receiving unanimous support from the voting shareholders.
Resolutions regarding the remuneration of auditors and the authority to allot relevant securities were passed with 92.64% and 83.96% of votes in favor, respectively. The disapplication of pre-emption rights in specified and additional circumstances was approved with 99.35% and 80.46% of the votes, respectively.
Uniphar, headquartered in Dublin, serves over 200 multinational pharmaceutical and medical technology manufacturers through its three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company is active across Europe, North America, APAC, and MENA regions, delivering to over 160 countries.
The AGM results reflect the shareholders’ confidence in Uniphar’s strategy and governance. The company continues to grow its service offerings and expand its market presence, aiming to improve patient access to healthcare products and treatments.
The detailed voting outcomes of the AGM, which showcase the company’s strong shareholder support, are available on Uniphar’s website. This announcement is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.